Dosage of adjuvant G-CSF (filgrastim)-supported FEC polychemotherapy based on equivalent haematological toxicity in high-risk breast cancer patients

Scandinavian Breast Group

Dosage of adjuvant G-CSF (filgrastim)-supported FEC polychemotherapy based on equivalent haematological toxicity in high-risk breast cancer patients

Scandinavian Breast Group

Research output: Contribution to journal › Article › Scientific › peer-review

23 Citations (Scopus)

Original language	English
Pages (from-to)	403-411
Journal	Annals of Oncology
Volume	9
Publication status	Published - 1998
Publication type	A1 Journal article-refereed

Access to Document

https://pubmed.ncbi.nlm.nih.gov/9636831

Cite this

@article{febb6908a6c64f46a07ae9ff88079341,

title = "Dosage of adjuvant G-CSF (filgrastim)-supported FEC polychemotherapy based on equivalent haematological toxicity in high-risk breast cancer patients",

author = "{Scandinavian Breast Group} and J Bergh and N Wilking and M Lehtinen and E Koivunen and T Wiklund and B Erikstein and T Fornander and N-O Bengtsson and P Malmstr{\"o}m and P Kellokumpu-Lehtinen and G Anker and H Bennharker",

year = "1998",

language = "English",

volume = "9",

pages = "403--411",

}

TY - JOUR

T1 - Dosage of adjuvant G-CSF (filgrastim)-supported FEC polychemotherapy based on equivalent haematological toxicity in high-risk breast cancer patients

AU - Scandinavian Breast Group

AU - Bergh, J

AU - Wilking, N

AU - Lehtinen, M

AU - Koivunen, E

AU - Wiklund, T

AU - Erikstein, B

AU - Fornander, T

AU - Bengtsson, N-O

AU - Malmström, P

AU - Kellokumpu-Lehtinen, P

AU - Anker, G

AU - Bennharker, H

PY - 1998

Y1 - 1998

M3 - Article

VL - 9

SP - 403

EP - 411

ER -